Point: The potential importance of elective nodal irradiation in the treatment of non-small cell lung cancer

Seminars in Radiation Oncology

Volumn 10, Issue 4, 2000, Pages 308-314

  Liengswangwong, Vichaivood ^a   Bonner, James A ^a  

^a The University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MEDIASTINUM LYMPH NODE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIATION DOSE; REVIEW;

EID: 0033788658     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2000.9279     Document Type: Article

References (49)

1. Cancer statistics, 1999
2. Non-small cell lung cancer
3. The national cancer database report on lung cancer
4. Clinical practice guidelines for the treatment of unresectable non-small lung cancer
5. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer: First analysis of a randomized trial in 353 patients
6. Effect of concomitant cisplatin and radiotherapy on inoperable non-small cell lung cancer
7. Three-dimensional radiation treatment planning study for patients with carcinoma of the lung
8. Mediastinal evaluation in lung cancer
9. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer
10. Mediastinal nodes in bronchogenic carcinoma: Comparison between CT and mediastinoscopy
11. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group
12. Bronchogenic carcinoma: Analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling
13. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer
14. Lymph node staging in non-small cell lung cancer with FDG-PET scan: A prospective studies on 690 lymph node stations from 68 patients
15. Preoperative thoracic staging of lung cancer: CT and MR evaluation
16. Bronchogenic carcinoma staging: CT vs. MR imaging - Assessment with surgery
17. Comparative merits of conventional computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung cancer
18. Primary lung cancer staging: Prospective comparative study of MR imaging with CT
19. A prospective evaluation of magnetic resonance imaging, computed tomography, and mediastinoscopy in the preoperative assessment of mediastinal node status in bronchogenic carcinoma
20. Frequency of noncontiguous lymph node involvement in patients with resectable non-small cell lung cancer
21. Skip mediastinal lymph node metastasis in non-small cell lung cancer
22. Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer
23. Extent of mediastinal node metastasis in clinical stage I non-small cell lung cancer
24. Frequency and distribution of occult micrometastases in the lymph nodes of patients with non-small cell lung carcinoma
25. Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small cell lung cancer
26. Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis
27. Micrometastatic p53-positive cells in the lymph nodes of non-small cell lung cancer: Prognostic significance
28. Randomized trial of lobectomy versus limited resection for T1 NO non-small cell lung cancer
29. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung
30. The role of surgery in N2 lung cancer
31. Radical systematic mediastinal lymphadenectomy in non-small cell lung cancer: A randomized controlled trial
32. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer
33. Effects of postoperative mediastinal radiation on completely resected stage II and III epidermold cancer of the lung
34. 0 disease
35. The impact of surgical adjuvant thoracic radiation therapy for non-small cell lung cancer patients with mediastinal nodal involvement
36. Patients with stage I non-small cell lung carcinoma at postoperative risk for local recurrence, distant metastasis, and death: Implications related to the design of clincial trials
37. Disseminated tumor cells in lymph nodes as a determinant for survival in surgically-resected non-small cell lung cancer
38. The role of postoperative radiotherapy for patients with completely resected non-small cell lung carcinoma
39. Predictors of subclinical nodal involvement in clinical stages I and II non-small cell lung cancer: Implications in the inoperable and three-dimensional dose-escalation settings
40. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?
41. Radiotherapy alone for medically inoperable stage I non-small cell lung cancer: The Duke Experience
42. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer
43. Results of combination chemotherapy and thoracic radiation therapy for unresectable non-small cell carcinoma of the lung
44. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung
45. Results of high-dose thoracic irradiation incorporating beam's eye view display in non-small cell lung cancer: A retrospective multivariate analysis
46. Dose escalation for non-small cell lung cancer using conformal radiation therapy
47. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer
48. Elective nodal irradiation in the treatment of non-small cell lung cancer with three-dimensional conformal radiation therapy (3D-CRT)
49. Incidental dose to clinically negative nodes from conformal treatment fields for non-small cell lung cancer